Anti-TNF-α treatment significantly mitigated the severity of ICI-related pneumonitis, suggesting that TNF-α+ T cells may be crucial for the pathogenesis of ICI-related pneumonitis and therapeutic targets for its intervention (Figure 2) (164). The gene discussed is TNF; the disease is pneumonitis.